Keywords: Sweden MPA, APIs, Environment, Manufacturing, EU, India, Developing countries, Certification, GMP

Swedish proposals for stricter environmental requirements for pharma industry could impact API makers in countries such as India

Article | 28 January 2010

• Print This

Under a commission from the Swedish government, the nation’s Medical Products Agency (MPA) has identified opportunities for strengthening the environmental requirements relating to the manufacturing of medicinal products with greatest emphasis on European Union and international efforts rather than national work. The report suggests, among other, the requirement for an environmental certification of the production facilities to be introduced to the legislation on Good Manufacturing Practice (GMP).

Results from Swedish research indicate that emissions from the manufacture of medicinal products in India are of an extent which might seriously affect human and animal health, as well as their environment. Enjoying this artcle? To continue reading you need to login, take a FREE trial or subscribe.